- Home
- » Tags
- » Tiotropium bromide
Top View
- Protocol for Non-Interventional Studies Based on Existing Data TITLE PAGE Document Number: C30445781-01
- Tiotropium Bromide)
- Preferred Drug List 4-Tier Small Group
- Inhaled Beta-Agonist Combination Agents
- Role of Ipratropium Bromide and Tiotropium in Chronic Obstructive Pulmonary Disease
- Inhaled Anticholinergics
- The Following Drugs Have Been Removed from the Madatory 90 Day
- Clozapine Induced Ogilvie's Syndrome
- Interactions with Experimental COVID-19 Therapies
- Outpatient Drug Formulary
- The Evidence on Tiotropium Bromide in Asthma: from the Rationale to the Bedside Dejan Radovanovic1, Pierachille Santus1, Francesco Blasi2 and Marco Mantero2*
- Stiolto Respimat Generic Name: Tiotropium Bromide and Olodaterol Manufacturer1: Boehringer Ingelheim
- Justification
- DOWNLOAD INKE Apis PRODUCT LIST
- Drug Formulary New York State Workers’ Compensation Effective August 7, 2019
- Drug Formulary New York State Workers’ Compensation Effective April 1, 2020
- Comparative Efficacy of Aclidinium Bromide 400 Μg BID Versus
- 209482Orig1s000
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Download Paper
- CDR Clinical Review Report for Trelegy Ellipta
- Patient Information SPIRIVA
- 205382Orig1s000
- Educational Aims • to Discuss Fundamental Questions Relating to the Use of Bronchodilators That Can Lead to an Optimisation of Their Utilisation
- Glossary of Medications
- Prescribing Information for SPIRIVA Handihaler
- Pharmaceuticals and Medical Devices Safety Information No
- Photosensitive Lichenoid Eruption Induced by Gabapentin
- Pharmacological Treatment of Chronic Obstructive Pulmonary Disease
- Glycopyrronium Bromide
- Thoraxjnl-2011-201275.Full.Pdf
- Chlorpromazine
- Attachment: Product Information: Tiotropium Bromide
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- LUTS Workshop 2018.Pdf
- CDR Pharmaceconomic Review Report for Incruse Ellipta
- SPIRIVA RESPIMAT Safely and Effectively
- Clinical Trials Appendix Full-Year and Q4 2016 Results Update
- March 2016 Effective March 30, 2016
- Tiotropium Bromide
- (COPD) Has Been Replaced with the Chart Below
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Vol-13 (2) 2012 JBSM.Pmd
- Respiratory Beta-Agonist Combination Agents
- Comparison of Tiotropium Bromide and Combined Ipratropium/Salbutamol for the Treatment of COPD: a UK General Practice Research Database 12-Month Follow-Up Study
- A Comparative Evaluation of Glycopyrronium Bromide, a Long-Acting
- 202450Orig1s000
- Supplementary Table 1 As Described in the Methods Section, for Every Medication, Odds Ratios
- 2019 Medicines in Development for Asthma and Allergy
- FDA Briefing Document
- In Vitro Assessment of Uptake and Lysosomal Sequestration of Respiratory Drugs in Alveolar Macrophage Cell Line NR8383
- Umeclidinium in Patients with COPD: a Randomised, Placebo-Controlled Study
- Incruse, INN-Umeclidinium Bromide
- Application to Add a Long Acting Muscarinic Agent (LAMA) Inhaler to the Essential Medicines List